scholarly article | Q13442814 |
P2093 | author name string | J H Johnson | |
A Ogawa | |||
M Ohneda | |||
R H Unger | |||
L Inman | |||
T Alam | |||
C T McAllister | |||
P2860 | cites work | An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone | Q73651729 |
Studies on antibody production. I. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit | Q33192868 | ||
Regulation of beta-cell glucose transporter gene expression | Q33603742 | ||
Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats | Q33757675 | ||
Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia | Q33927457 | ||
The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence | Q33985925 | ||
Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects | Q35903867 | ||
Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate | Q37412738 | ||
Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells | Q37671830 | ||
Insulin secretion in diabetes mellitus | Q40302183 | ||
Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians | Q51023388 | ||
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. | Q54427953 | ||
31 The in Vitro perfused pancreas | Q66898297 | ||
Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes | Q68598308 | ||
Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus | Q68930016 | ||
Isolation of RNA using guanidinium salts | Q69005967 | ||
Decreased Sensitivity of the Pancreatic Beta Cells to Glucose in Prediabetic and Diabetic Subjects: A Glucose Dose-Response Study | Q69166799 | ||
Levels of Plasma Insulin During Cortisone Glucose Tolerance Tests in “Nondiabetic” Relatives of Diabetic Patients: Implications of Diminished Insulin Secretory Reserve in Subclinical Diabetes | Q71405495 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | insulin resistance | Q1053470 |
dexamethasone | Q422252 | ||
P304 | page(s) | 497-504 | |
P577 | publication date | 1992-08-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes | |
P478 | volume | 90 |
Q36402808 | 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice |
Q64256355 | A case of nivolumab-induced acute-onset type 1 diabetes mellitus in melanoma |
Q74446261 | Acute glucosuria after continuous glucocorticoid loading in the rat in vivo |
Q42503449 | Acute impairment of insulin signalling by dexamethasone in primary cultured rat skeletal myocytes |
Q51109817 | Age- and gender-related changes in glucose homeostasis in glucocorticoid-treated rats. |
Q54232955 | Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. |
Q42516330 | Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects |
Q35883220 | Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships |
Q42484710 | Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence |
Q34797310 | Correction of Diabetic Hyperglycemia and Amelioration of Metabolic Anomalies by Minicircle DNA Mediated Glucose-Dependent Hepatic Insulin Production |
Q41478915 | Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes. |
Q58088444 | Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic β Cells |
Q41115408 | Dexamethasone induces neuropeptide Y (NPY) expression and impairs insulin release in the insulin-producing cell line RINm5F. Release of NPY and insulin through different pathways |
Q39777522 | Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets |
Q36126014 | Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats |
Q92360790 | Effect of high-dose dexamethasone on patients without diabetes during elective neurosurgery: a prospective study |
Q42869465 | Effect of insulin plant leaves on dexamethasone-induced hyperglycemia |
Q48479986 | Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature |
Q38007405 | Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development |
Q39201766 | Experimental model of glucocorticoid-induced insulin resistance |
Q36702009 | Fat feeding potentiates the diabetogenic effect of dexamethasone in Wistar rats |
Q38734745 | G6PC2 Modulates the Effects of Dexamethasone on Fasting Blood Glucose and Glucose Tolerance |
Q33905579 | GLUT-2 function in glucose-unresponsive beta cells of dexamethasone-induced diabetes in rats |
Q36534752 | GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic beta cells and insulinoma: evidence for a block in trans-Golgi network exit by brefeldin A. |
Q44981899 | Genetic contributions to glucose intolerance in polycystic ovary syndrome |
Q89573972 | Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis |
Q44058136 | Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate |
Q48184307 | Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion |
Q27865298 | Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression |
Q37099313 | Hypoglycaemic and anti-diabetic activity of stem bark extracts Erythrina indica in normal and alloxan-induced diabetic rats |
Q47187977 | Hypoglycemic Effect of Chinese Yam (Dioscorea opposita rhizoma) Polysaccharide in Different Structure and Molecular Weight. |
Q26741374 | Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence |
Q53481760 | Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats. |
Q84609518 | Influence of topical dexamethasone applications on insulin, glucose, thyroid hormone and cortisol levels in dogs |
Q36266034 | Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role? |
Q72519246 | Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis |
Q54105933 | Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. |
Q72134551 | Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats |
Q43190955 | JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats. |
Q71212575 | Loss of GLUT2 glucose transporter expression in pancreatic beta cells from diabetic Chinese hamsters |
Q46957183 | MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice |
Q28535673 | Meta-modeling of methylprednisolone effects on glucose regulation in rats |
Q34093081 | Multiple epidural steroid injections and body mass index linked with occurrence of epidural lipomatosis: a case series |
Q33798117 | Neuropeptide Y expression marks partially differentiated β cells in mice and humans |
Q58788416 | New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog |
Q41314761 | Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure. |
Q61455366 | Polysaccharide-Enriched Fraction from Fruiting Body Improves Insulin Resistance |
Q38555446 | Regulation of Glucose Homeostasis by Glucocorticoids |
Q84511902 | Serum thyroid hormone, insulin, glucose, triglycerides and protein concentrations in normal horses: association with topical dexamethasone usage |
Q48137778 | Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 Mice. |
Q42105383 | Unforeseen role for glucocorticoids in combinatorial anti-obesity pharmacology |
Q71095042 | [Insulin producing cells as therapy in diabetes mellitus] |
Q41124928 | cAMP prevents the glucose-mediated stimulation of GLUT2 gene transcription in hepatocytes |
Search more.